EDDA Technology
Private Company
Total funding raised: $45M
Overview
EDDA Technology is an innovative leader in computer-assisted radiology and surgery, focusing on precision oncology. Its core IQQA® platform leverages AI and machine learning to transform standard 2D CT and MRI scans into interactive, quantitative 3D models, enabling detailed surgical planning and real-time navigation. The company's solutions are commercial-stage, deployed in hospitals to support complex procedures like liver resections, lung segmentectomies, and kidney partial nephrectomies. By targeting the growing field of image-guided precision surgery, EDDA seeks to establish a standard of care in surgical oncology and interventional radiology.
Technology Platform
IQQA® platform: An AI/ML-driven software suite for fully quantitative, real-time interactive 3D medical image analysis, segmentation, surgical planning/simulation, and intra-operative navigation. It transforms 2D CT/MRI into patient-specific 3D models for liver, lung, and kidney procedures.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
EDDA competes with large medical imaging and navigation companies like Medtronic (StealthStation), Johnson & Johnson (Cerenovus, Verb Surgical), and Siemens Healthineers, which offer integrated hardware-software solutions. It also faces competition from other AI-powered surgical planning startups such as Therenva, Intuitive Surgical (with its integrated planning), and specialized software firms in radiology AI. EDDA's differentiation lies in its organ-specific, quantitative, end-to-end platform focused purely on enabling complex cancer surgeries.